Chinese Journal of New Drugs and Clinical Remedies 2010 Issue 4 Investigation and intervention measures on clinical application of traditional Chinese medicine injections activating blood circulation and resolving stasis

Investigation and intervention measures on clinical application of traditional Chinese medicine injections activating blood circulation and resolving stasis
SHAO Hua1a;LIU Nai-feng1b;2;XU Hou-ming3;LI Wei-lan1a;CAI Lin-ling1a;XIE Han1a

..............page:315-318

zhong guo xin yao yu lin chuang za zhi bei shi jie wei sheng zu zhi xi tai ping yang di qu yi xue suo yin (wprim) shou lu

..............page:250

Consideration about current non-clinical safety evaluation of Chinese materia medica and naturally occurring drug from FDA’ s botanical drug registration case
ZHANG Xiao-dong1;2;LI Lian-da1

..............page:251-255

5-serotonin and norepinephrine reuptake inhibitor is first line drug for anxiety disorder
SU Hui;JIANG Kai-da;XU Yi-feng

..............page:264-269

Advance of trastuzumab in treatment of human epidermal growth factor receptor-2-positive gastric cancer
LI Xiao-ling1;XU Jian-ming2

..............page:260-263

guan yu tui jian 2010 nian zhong guo yao xue hui ke xue ji shu jiang de tong zhi

..............page:305

Comparative effects between rosuvastatin and atorvatatin on cardiac fibroblasts proliferation and collagen synthesis of neonatal rat
WANG Qian1;CUI Wei1;ZHANG Hai-lin2;LI Ya1;ZHAO Hui1;LU Jing-chao1

..............page:301-305

ben kan zheng ( wu ) yi yong ( bu yi yong ) de zi he shu yu ju li

..............page:300

Verification of "Effects of Sinupret on acute sinusitis in 100 patients" published by "Chinese Journal of New Drugs and Clinical Remedies"
GAO Ming

..............page:319-320

guan yu tui jian 2010 nian zhong guo yao xue hui - sai nuo fei an wan te qing nian sheng wu yao wu jiang de tong zhi

..............page:269

Pharmacokinetics of faropenem by intravenous infusion in Chinese healthy volunteers
SUN Li;SU Ke-jian;LIU Jing;SHEN Jin-fang

..............page:296-300

Close meeting with U. S. Food and Drug Administration for new drug development
Mukesh KUMAR1;MAO Yuan-sheng2

..............page:279-282

Consideration about quality control of Chinese medicine from first botanical drug product approved by America
HAN Wei1;2;ZHOU Gang1;KANG Ting-guo2

..............page:244-247

Investigational new drug application of Chinese herbal medicine in U. S. and regulatory requirements of U. S. Food and Drug Administration
Mukesh KUMAR1;MAO Yuan-sheng2;Keith CHAN3

..............page:241-243

zhong guo xin yao yu lin chuang za zhi ( yuan ming xin yao yu lin chuang )2010 nian zheng ding

..............page:263

Meta-analysis of Shengmai injection and conventional therapy for coronary heart disease
ZHANG Qian;JIN Ruo-min

..............page:310-314

Safety of immunotherapy with standardized mites allergens in 195 children with allergic asthma
CHEN Yun;HUANG Ying;WANG Mo-kui;CHEN Kun-hua;JIANG Yong-hui

..............page:292-295

guan yu tui jian 2010 nian zhong guo yao xue hui - shi yao ji tuan qing nian yao ji xue jiang de tong zhi

..............page:273

zhong guo xin yao yu lin chuang za zhi 2009 nian du te yao shen gao ren ming dan

..............page:286

Clinical study and evaluation strategy of botanical drug in U. S. based on approval of veregen
ZHU Fei-peng;L Jia-kang

..............page:256-259

Nuclear factor kappa B, pyrrolidine dithiocarbamate and asthma
LI Jie;WANG Zhi-qiang

..............page:270-273

Application of ranolazine in treatment of cardiovascular diseases
HUANG Zhen-hua

..............page:283-286

Reference of first botanical drug product approved by America to non-clinical pharmacodynamics evaluation of Chinese herbs
ZHU Fei-peng

..............page:248-250

Application and safety of itraconazole in children
TANG Wei-ping1;LIU Xiang-qian2

..............page:274-278

guan yu ping xuan di 13 jie zhong guo yao xue hui - shi wei ya qing nian yao wu hua xue jiang he zhuan xiang yan jiu zi zhu xiang mu de tong zhi

..............page:278

Effects of Shenle capsule on nephritis rabbit models and 5/6 nephrectomy rats
WEI Ri-bao;ZHANG Wu-xing;SHI Suo-zhu;CHEN Xiang-mei

..............page:287-291

Down-regulating effects of Coriolus versicolor polysaccharopeptide on murine macrophage production of inflammatory mediators induced by lipopolysaccharide
REN Wen-zhi1;YANG Xiao-tong1;2;MA Wei-chao1;FENG Hui-qin1;YANG Ming-jun1;YANG Qin-yao2;DONG Sha-sha1

..............page:306-309